SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Total Liabilities and Equity
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Total Liabilities and Equity of $22.81 million as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-09-24
- 2026-06-30: Liabilities and Equity $22.81M.
- 2026-03-31: Liabilities and Equity $11.81M.
- 2025-12-31: Liabilities and Equity $10.48M.
- 2025-09-30: Liabilities and Equity $3.54M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $22.81M 10-Q · filed 2026-09-24 |
| 2026-03-31 | $11.81M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $10.48M 10-Q · filed 2026-09-24 |
| 2025-09-30 | $3.54M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.50M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $5.31M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.51M 10-K · filed 2026-03-31 |
| 2024-09-30 | $673.57K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.81M 10-Q · filed 2024-09-04 |
| 2024-03-31 | $4.75M 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $5.95M 10-K · filed 2025-02-26 |
| 2023-09-30 | $7.38M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $8.84M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.44M 10-Q · filed 2023-05-25 |
| 2022-12-31 | $8.65M 10-K/A · filed 2024-09-04 |
| 2022-09-30 | $9.38M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $651.64K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |